標(biāo)題: Titlebook: Cancer Treatment: An Interdisciplinary Approach; Nima Rezaei Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive li [打印本頁] 作者: exposulate 時間: 2025-3-21 19:47
書目名稱Cancer Treatment: An Interdisciplinary Approach影響因子(影響力)
書目名稱Cancer Treatment: An Interdisciplinary Approach影響因子(影響力)學(xué)科排名
書目名稱Cancer Treatment: An Interdisciplinary Approach網(wǎng)絡(luò)公開度
書目名稱Cancer Treatment: An Interdisciplinary Approach網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cancer Treatment: An Interdisciplinary Approach被引頻次
書目名稱Cancer Treatment: An Interdisciplinary Approach被引頻次學(xué)科排名
書目名稱Cancer Treatment: An Interdisciplinary Approach年度引用
書目名稱Cancer Treatment: An Interdisciplinary Approach年度引用學(xué)科排名
書目名稱Cancer Treatment: An Interdisciplinary Approach讀者反饋
書目名稱Cancer Treatment: An Interdisciplinary Approach讀者反饋學(xué)科排名
作者: 暫時別動 時間: 2025-3-21 22:28 作者: 流動性 時間: 2025-3-22 02:51 作者: 博識 時間: 2025-3-22 05:51
SpringerBriefs in Cancer Researchlinical relevance, and the physiopathological mechanisms leading to ICI-related ATIN..Moreover, we describe the diagnostic approach to adopt in case of acute kidney injury onset in a patient in treatment with ICIs, pinpointing the importance of histopathology which enables a certain differential dia作者: 叫喊 時間: 2025-3-22 09:09 作者: GONG 時間: 2025-3-22 15:34 作者: GONG 時間: 2025-3-22 20:58 作者: Ataxia 時間: 2025-3-22 21:44 作者: 圓錐體 時間: 2025-3-23 04:20 作者: photopsia 時間: 2025-3-23 07:54
Recent Innovative Approaches to Intensify the Efficacy and Safety of CAR-T Cell Therapy in Cancers,t, cause the need for crucial control of their activity. Accordingly, enhancing the therapeutic potential of CAR-T cells with combination therapies and improving both the efficiency and safety of these cells by equipping them with genetic engineering methods would help to better respond to tumors. H作者: syncope 時間: 2025-3-23 10:14 作者: 不持續(xù)就爆 時間: 2025-3-23 17:36 作者: Gingivitis 時間: 2025-3-23 19:03
The Effects of Low-Dose Non-ionizing and Ionizing Radiation on Wound Healing and Cancer,heir healing capacity. These disruptions of the skin’s structural and functional integrity go through four distinct phases to achieve complete wound healing, namely, haemostasis, inflammation, cellular migration and proliferation and remodelling. Photobiomodulation and low-dose ionizing radiation ha作者: 污穢 時間: 2025-3-23 23:11 作者: 神秘 時間: 2025-3-24 05:34 作者: 古代 時間: 2025-3-24 08:13 作者: Homocystinuria 時間: 2025-3-24 10:51
2731-4561 (USERN). This interdisciplinary book will be of special value for researchers and clinicians who wish to extend their knowledge on cancer treatment..978-3-031-43985-8978-3-031-43983-4Series ISSN 2731-4561 Series E-ISSN 2731-457X 作者: Serenity 時間: 2025-3-24 16:00
Book 2023o new therapeutic approaches, including targeted therapy, immunotherapy, stem cell transplantation, and hormone therapy. Therefore, an interdisciplinary approach is needed to find a better therapeutic protocols in order to increase the prognosis and quality of life of patients with cancer...The seco作者: 懲罰 時間: 2025-3-24 19:39 作者: Intercept 時間: 2025-3-25 00:17
J. L. Sanz,E. Martínez-Gonzálezo-date issues related to tumor immunology and immunotherapy, including innate immunity, adaptive immunity, different therapeutic approaches, including dendritic cells, T cells, antibodies, cancer vaccines, checkpoint blockade, and the future trends in clinical trials applying immunotherapy.作者: Capture 時間: 2025-3-25 06:03 作者: strain 時間: 2025-3-25 10:04
A.A. Klypin,I.A. Strukov,D.P. Skulacheves in cancer research. This chapter is an interdisciplinary collaboration of scientists from different fields of science, in which the contribution of different disciplines to cancer research is reviewed. In addition, the framework of cancer research in 2050 is depicted as a guide for future research.作者: 名義上 時間: 2025-3-25 12:32 作者: preservative 時間: 2025-3-25 16:27
https://doi.org/10.1007/978-3-642-83647-3d separately. An update on the conducted clinical trials implementing various manipulative methods and their outcomes are also provided. Apparently, designed or manipulated grafts have provided a safe platform for improving HSCT outcomes.作者: glucagon 時間: 2025-3-25 20:57
https://doi.org/10.1007/978-3-642-83320-5ing any recommendation against thinking of HBOT for all. However, clinical trials are ongoing and might change the future picture of this field. In addition, the interdisciplinary research can approach further by relating the physics of HBOT and cancer biomechanics and scheduling standard protocols of HBOT for cancer.作者: 舊石器時代 時間: 2025-3-26 02:27 作者: Fretful 時間: 2025-3-26 05:25
Cancer: A Complex Problem Requiring Interdisciplinary Research,es in cancer research. This chapter is an interdisciplinary collaboration of scientists from different fields of science, in which the contribution of different disciplines to cancer research is reviewed. In addition, the framework of cancer research in 2050 is depicted as a guide for future research.作者: 錯事 時間: 2025-3-26 10:02 作者: 責(zé)難 時間: 2025-3-26 12:54
Immunological Properties of Manipulated Hematopoietic Stem Cell Grafts,d separately. An update on the conducted clinical trials implementing various manipulative methods and their outcomes are also provided. Apparently, designed or manipulated grafts have provided a safe platform for improving HSCT outcomes.作者: Gullible 時間: 2025-3-26 16:54 作者: Orthodontics 時間: 2025-3-27 00:10
Interventional Oncology Techniques: A Primer for Non-users,reatment and comfort in cancer patients. The purpose of the current chapter is to focus on the current role of interventional oncology procedures for curative or palliative treatment of a wide variety of cancer pathologies.作者: Overstate 時間: 2025-3-27 01:47 作者: 舔食 時間: 2025-3-27 05:25
https://doi.org/10.1007/978-3-642-83647-3ity relationship, molecular docking studies and their mechanism. Therefore, this compilation could assist the global researchers to develop novel and potent quinolone-based therapeutics to treat various cancerous conditions.作者: 搜尋 時間: 2025-3-27 11:52 作者: Parallel 時間: 2025-3-27 16:12
New Approaches Targeting Immuno-oncology and Tumor Microenvironment,X40, CD137, IOS, GITA and CD27. Targeting immunosuppressive cells and antitumor by combining targeted drugs with PD-1/PD-L1 antibodies may also improve clinical outcomes and overcome immune resistance.作者: 話 時間: 2025-3-27 21:41
,Recent Development of Quinoline Derivatives as Anticancer Agents: 2015–2022,ity relationship, molecular docking studies and their mechanism. Therefore, this compilation could assist the global researchers to develop novel and potent quinolone-based therapeutics to treat various cancerous conditions.作者: mercenary 時間: 2025-3-27 23:45 作者: 面包屑 時間: 2025-3-28 02:59 作者: Gullible 時間: 2025-3-28 09:49 作者: INTER 時間: 2025-3-28 12:18 作者: 裝飾 時間: 2025-3-28 17:40 作者: Ornament 時間: 2025-3-28 19:50 作者: Infusion 時間: 2025-3-29 02:00
An Updated Focus on Immune Checkpoint Inhibitors and Tubulointerstitial Nephritis,kpoint inhibitors (ICIs), which are currently widely used as new efficient therapeutic weapons in medical oncology. ICIs are monoclonal antibodies specifically designed to disrupt the inhibitory activity of immune checkpoints to enable the T lymphocyte-mediated recognition and elimination of tumor c作者: 高談闊論 時間: 2025-3-29 04:12
Cancer Stem Cell as a Target for Immunotherapeutic Approach,unotherapeutic approaches. Cancer stem cells are a group of tumor cells with the ability to self-renewal and initiation of cancer growth. In this chapter, we try to demonstrate the immunological features and pathways of cancer stem cells which open up a way to consider them as a therapeutic target. 作者: 講個故事逗他 時間: 2025-3-29 07:56 作者: Heterodoxy 時間: 2025-3-29 11:26
,Recent Development of Quinoline Derivatives as Anticancer Agents: 2015–2022,, in pursuit of new molecules scientists came across quinoline, a privileged scaffold that has been associated with multiple biological activities like antiviral, antibacterial, antimalarial, antifungal, antitubercular, antileishmanial, anti-inflammatory, anti-HIV, and anticancer. This multifarious 作者: 諷刺 時間: 2025-3-29 15:52 作者: 黑豹 時間: 2025-3-29 22:38
The Use of Immunotherapy in Cancer Patients with Autoimmune Diseases,us tumor types. Through stimulating the immune system, patients with autoimmune disorders (AIDs) were often excluded for clinical trials. The aim of this chapter is to discuss the use of ICIs in patients with AIDs. Evidence for using various types of ICIs [cytotoxic T-lymphocyte-associated protein 4作者: Conduit 時間: 2025-3-30 02:20
The Effects of Low-Dose Non-ionizing and Ionizing Radiation on Wound Healing and Cancer,cer, low-dose radiation (LDR), typically <100?mGy, shows the capacity to improve wound healing by promoting fibroblast-to-myofibroblast differentiation, matrix deposition, keratinocyte proliferation and angiogenesis. Moreover, animal studies have shown LDR attenuates systemic acute inflammatory resp作者: 逢迎春日 時間: 2025-3-30 06:18 作者: 故意 時間: 2025-3-30 09:46 作者: Commentary 時間: 2025-3-30 13:21 作者: 辯論的終結(jié) 時間: 2025-3-30 19:05 作者: harangue 時間: 2025-3-30 20:42
Cancer Treatment: An Interdisciplinary Approach978-3-031-43983-4Series ISSN 2731-4561 Series E-ISSN 2731-457X 作者: Expressly 時間: 2025-3-31 04:43 作者: Duodenitis 時間: 2025-3-31 08:00 作者: MULTI 時間: 2025-3-31 11:06 作者: 邪惡的你 時間: 2025-3-31 14:15
978-3-031-43985-8The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: blister 時間: 2025-3-31 19:28
A.A. Klypin,I.A. Strukov,D.P. Skulachevation of complex problems not being solved using a single discipline has directed scientists toward interdisciplinary approaches. Cancer is a complex problem that, regardless of great advances in different scientific fields, remains to be properly addressed. Early diagnosis, personalized treatment, 作者: 鳥籠 時間: 2025-3-31 22:24
J. L. Sanz,E. Martínez-Gonzálezd elicit a response against tumor cells. However, tumor cells also have mechanisms to evade the immune system. This chapter focuses on discussing up-to-date issues related to tumor immunology and immunotherapy, including innate immunity, adaptive immunity, different therapeutic approaches, including
